We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

544 hedge funds and large institutions have $2.01B invested in iShares US Medical Devices ETF in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 152 increasing their positions, 224 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $18.6M | Put options by funds: $12.7M

3.75% more ownership

Funds ownership: 35.74%39.49% (+3.8%)

7% less funds holding

Funds holding: 585544 (-41)

8% less capital invested

Capital invested by funds: $2.19B → $2.01B (-$185M)

32% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 224

40% less funds holding in top 10

Funds holding in top 10: 159 (-6)

46% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 80

Holders
544
Holders Change
-41
Holders Change %
-7.01%
% of All Funds
8.63%
Holding in Top 10
9
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-40%
% of All Funds
0.14%
New
43
Increased
152
Reduced
224
Closed
80
Calls
$18.6M
Puts
$12.7M
Net Calls
+$5.93M
Net Calls Change
+$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
HWM
376
Howard Wealth Management
Connecticut
$257K -$16.5K -310 -6%
CAM
377
Cresset Asset Management
Illinois
$254K +$2.98K +56 +1%
SIGI
378
Susquehanna International Group (Ireland)
Ireland
$251K +$275K +5,165 New
MIA
379
MMBG Investment Advisors
Florida
$247K
Envestnet Portfolio Solutions
380
Envestnet Portfolio Solutions
Illinois
$247K +$271K +5,088 New
AWA
381
Acorn Wealth Advisors
Michigan
$241K -$16.1K -303 -6%
SWM
382
SeaCrest Wealth Management
New York
$241K -$1.59K -30 -0.6%
BIA
383
Biondo Investment Advisors
Pennsylvania
$240K +$11.4K +215 +5%
FFN
384
Focus Financial Network
Minnesota
$239K -$36.8K -692 -12%
SFP
385
Sterling Financial Planning
New Jersey
$239K +$6.91K +130 +3%
RJT
386
Raymond James Trust
Florida
$235K +$48.3K +908 +23%
AIM
387
Acropolis Investment Management
Missouri
$233K
BBWP
388
Beacon Bridge Wealth Partners
Pennsylvania
$232K -$50.3K -946 -16%
NFSG
389
Newbridge Financial Services Group
Florida
$232K -$37.5K -705 -13%
MFG
390
Merit Financial Group
Georgia
$232K +$51.3K +964 +25%
SFI
391
SPC Financial Inc
Maryland
$230K
FAM
392
Forte Asset Management
New York
$228K
DFA
393
DHK Financial Advisors
New Hampshire
$227K
PCIA
394
Prime Capital Investment Advisors
Kansas
$222K +$2.55K +48 +1%
PFG
395
Prosperity Financial Group
California
$214K -$26.6K -500 -10%
FIA
396
Foundations Investment Advisors
Arizona
$213K -$37.1K -698 -14%
FFA
397
Farther Finance Advisors
California
$209K +$180K +3,389 +371%
SS
398
Simplicity Solutions
Minnesota
$206K -$286K -5,370 -56%
BFG
399
Bleakley Financial Group
New Jersey
$206K +$32K +602 +16%
OIA
400
OneDigital Investment Advisors
Kansas
$205K -$550K -10,345 -71%

IHI Hedge Fund Activity: Q3 2023 in Review

544 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2023, worth a combined $2.01B — down 8.4% from $2.19B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of IHI and 43 opened new positions — a net loss of 37 holders — while 224 trimmed existing stakes and 152 added.

The largest buyer was Bank of America, adding an estimated $50.2M. The largest seller was Morgan Stanley, cutting an estimated $34.4M.

  • 544 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2023, down from 585 in Q2 2023.
  • Funds reported $2.01B of iShares US Medical Devices ETF stock for Q3 2023, down 8.4% quarter-over-quarter.
  • 43 funds opened new iShares US Medical Devices ETF positions in Q3 2023 and 80 closed out, a net change of -37 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2023 was Bank of America, an estimated $50.2M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2023 was Morgan Stanley, an estimated $34.4M sold.

Based on aggregated 13F filings for Q3 2023.